SCHEMBL18566699

SCHEMBL18566699

CCCN/C=C(\C=N)NC

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.36
ADH1A P07327 1/20 0.36
ADH7 P40394 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21280277 0.73
SCHEMBL23131335 0.71
SCHEMBL18080898 0.71
SCHEMBL8178196 0.71
SCHEMBL26347134 0.70
SCHEMBL22702057 0.70
SCHEMBL26351628 0.68 ADH1B (0.39) ADH1BADH1AADH7
SCHEMBL25801503 0.68 ADH1B (0.34) ADH1BADH1AADH7
SCHEMBL24152958 0.67 ADH1B (0.34) ADH1BADH1AADH7
SCHEMBL1895673 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3135668-A1 NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2017-03-01 EP disclosed